Helsing M - Search Results

1

Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer.

Possinger K, Kaufmann M, Coleman R, Stuart NS, Helsing M, Ohnmacht U, Arning M. Possinger K, et al. Among authors: helsing m. Anticancer Drugs. 1999 Feb;10(2):155-62. doi: 10.1097/00001813-199902000-00003. Anticancer Drugs. 1999. PMID: 10211545 Clinical Trial.

2

Treatment with paclitaxel 1-h infusion and carboplatin of patients with advanced non-small-cell lung cancer: a phase II multicentre trial. Joint Lung Cancer Study Group.

Helsing M, Thaning L, Sederholm C, Lamberg K, Martinsson JE, Ek L, Månsson T, Andersson L, Hero U, Anjedani D, Svennson G. Helsing M, et al. Lung Cancer. 1999 May;24(2):107-13. doi: 10.1016/s0169-5002(99)00027-6. Lung Cancer. 1999. PMID: 10444061 Clinical Trial.

3

The prognostic importance of myelosuppression in the response to chemotherapy and survival in advanced ovarian carcinoma.

Sorbe B, Helsing M. Sorbe B, et al. Among authors: helsing m. Cancer. 1987 Feb 15;59(4):690-4. doi: 10.1002/1097-0142(19870215)59:4<690::aid-cncr2820590405>3.0.co;2-y. Cancer. 1987. PMID: 3802028

4

Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, alpha-interferon (leucocyte) and tamoxifen.

Henriksson R, Nilsson S, Colleen S, Wersäll P, Helsing M, Zimmerman R, Engman K. Henriksson R, et al. Among authors: helsing m. Br J Cancer. 1998 Apr;77(8):1311-7. doi: 10.1038/bjc.1998.218. Br J Cancer. 1998. PMID: 9579838 Free PMC article. Clinical Trial.

5

Quality of life and survival in patients with advanced non-small cell lung cancer receiving supportive care plus chemotherapy with carboplatin and etoposide or supportive care only. A multicentre randomised phase III trial. Joint Lung Cancer Study Group.

Helsing M, Bergman B, Thaning L, Hero U. Helsing M, et al. Eur J Cancer. 1998 Jun;34(7):1036-44. doi: 10.1016/s0959-8049(97)10122-8. Eur J Cancer. 1998. PMID: 9849452 Clinical Trial.

6

Prognostic factors for the survival of surgically treated patients for non-small cell lung cancer.

Fernandes OJ, Almgren SO, Thaning L, Filbey D, Helsing M, Karlsson M, Magnusson A, Souza D. Fernandes OJ, et al. Among authors: helsing m. Acta Oncol. 2003;42(4):338-41. doi: 10.1080/02841860310003536. Acta Oncol. 2003. PMID: 12899506

7

Swedish lung cancer radiation study group: predictive value of histology for radiotherapy response in patients with non-small cell lung cancer.

Holgersson G, Bergström S, Bergqvist M, Nyman J, Hoye E, Helsing M, Friesland S, Holgersson M, Birath E, Ekman S, Blystad T, Ewers SB, Mörth C, Löden B, Henriksson R. Holgersson G, et al. Among authors: helsing m. Eur J Cancer. 2011 Nov;47(16):2415-21. doi: 10.1016/j.ejca.2011.06.011. Epub 2011 Jul 2. Eur J Cancer. 2011. PMID: 21726999

8

The value of induction chemotherapy for survival in patients with non-small cell lung cancer treated with radiotherapy.

Holgersson G, Sandelin M, Hoye E, Bergström S, Henriksson R, Ekman S, Nyman J, Helsing M, Friesland S, Brodin O, Holgersson M, Lundström KL, Janson C, Ekberg L, Mörth C, Blystad T, Ewers SB, Löden B, Bergqvist M. Holgersson G, et al. Among authors: helsing m. Anticancer Res. 2012 Apr;32(4):1339-46. Anticancer Res. 2012. PMID: 22493368

9

Swedish Lung Cancer Radiation Study Group: predictive value of age at diagnosis for radiotherapy response in patients with non-small cell lung cancer.

Holgersson G, Hoye E, Bergqvist M, Ekman S, Nyman J, Helsing M, Friesland S, Holgersson M, Ekberg L, Blystad T, Ewers SB, Mörth C, Löden B, Henriksson R, Bergström S. Holgersson G, et al. Among authors: helsing m. Acta Oncol. 2012 Jul;51(6):759-67. doi: 10.3109/0284186X.2012.681064. Acta Oncol. 2012. PMID: 22793039

10

The impact of hyperfractionated radiotherapy regimen in patients with non-small cell lung cancer.

Holgersson G, Bergqvist M, Nyman J, Hoye E, Helsing M, Friesland S, Holgersson M, Ekberg L, Mörth C, Ekman S, Blystad T, Ewers SB, Löden B, Henriksson R, Bergström S. Holgersson G, et al. Among authors: helsing m. Med Oncol. 2013 Mar;30(1):320. doi: 10.1007/s12032-012-0320-y. Epub 2012 Dec 18. Med Oncol. 2013. PMID: 23254960

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19 results

Search Page

Filters